Salix Pharmaceuticals, Ltd. Buys IP Rights Connected to Top Moneymaker

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Salix Pharmaceuticals, Raleigh’s largest homegrown drug company, acquired various intellectual property rights for products that would relate to its highest revenue drug. Salix (Nasdaq: SLXP) announced Thursday it bought one patent application and one issued patent related to rifaximin, a drug which Salix sells under the brand name Xifaxan and which recorded $514 million in sales in 2012, or 70 percent of total revenues.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC